Cargando…
Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series
PURPOSE: Dry eye disease is a highly prevalent condition that causes tear film instability, ocular discomfort, and visual disturbance. Lacrimera eye drops are approved for the short-term treatment of dry eye disease. We aimed to evaluate the clinical outcome of patients with moderate-to-severe dry e...
Autores principales: | Nepp, Johannes, Knoetzl, Wolfgang, Prinz, Anna, Hoeller, Sonja, Prinz, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242486/ https://www.ncbi.nlm.nih.gov/pubmed/32124131 http://dx.doi.org/10.1007/s10792-020-01324-5 |
Ejemplares similares
-
Occurrence of Corneal Staining after Cataract Surgery with and without Chitosan-N-Acetylcysteine Eye Drops
por: Palkovits, Stefan, et al.
Publicado: (2023) -
Comparing the efficacy of sodium hyaluronate eye drops and carboxymethylcellulose eye drops in treating mild to moderate dry eye disease
por: Salim, Sreelakshmi, et al.
Publicado: (2023) -
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017) -
The use of preservatives in dry eye drops
por: Walsh, Karen, et al.
Publicado: (2019) -
Autologous Serum Eye Drops for Dry Eye: Systematic Review
por: Quan, Nicolas G., et al.
Publicado: (2023)